Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IMRX
#3221
Immuneering Corporation Class A Common Stock
5.4
1
USD
-5.09%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
-5.09%
Mudança mensal
+7.13%
Mudança em 6 meses
-9.53%
Mudança anual
+300.74%
Fechamento anterior
5.7
0
Abrir
5.4
1
Bid
Ask
Mínimo
5.4
1
High
5.4
1
Volume
55
Mercados
Ações
Cuidados de saúde
IMRX
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
26.38 M
26.44 M
29.28 M
35.89 M
64.65 M
—
Valuation ratios
Enterprise value
351.63 M
33.37 M
154.95 M
42.81 M
296.77 M
636.07 M
Price to earnings ratio
-6.57
-2.11
-3.89
-1.08
-5.18
-11.64
Price to sales ratio
105.83
333.84
—
3 435.39
—
—
Price to cash flow ratio
-7.13
-2.4
-4.25
-1.2
-6.39
-14.23
Price to book ratio
1.41
0.96
2.3
1.59
1.33
2.96
Enterprise value to EBITDA ratio
-35.6
-4.77
-9.88
-3.15
-19.43
-44.46
Profitability ratios
Return on assets %
-0.2
-0.41
-0.52
-1.16
-0.24
-0.77
Return on equity %
-0.22
-0.46
-0.59
-1.47
-0.26
-0.98
Return on invested capital %
-917.13
-1 049.04
-619.87
-1 405.29
-441.24
—
Gross margin %
44.56
50.11
—
100
—
—
Operating margin %
-1 629.17
-16.33 K
—
-333.71 K
—
—
EBITDA margin %
-1 626.98
-16.24 K
—
-331.75 K
—
—
Net margin %
-1 612.33
-15.94 K
—
-317.9 K
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
27.04
13.5
11.35
5.28
17.5
52.68
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-2.27
-1.67
-1.72
-1.83
-1.03
-1.18
EBIT per share
-2.49
-1.96
-2.06
-2.14
-1.35
-1.55
EBITDA per share
-2.49
-1.95
-2.08
-2.12
-1.34
-1.54
Total debt per share
—
—
—
—
—
—
Cash per share
10.96
4
3.01
1.21
2.92
10.4
Net current asset value per share
11.19
4.12
3.13
1.32
4
11.63
Tangible book value per share
10.93
3.89
2.94
1.15
4.8
11.96
Working capital per share
10.78
3.82
2.86
1.07
3.78
10.8
Book value per share
11.46
4.16
3.19
1.38
4.96
12.69
Notícias
The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying
3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts - TipRanks.com
Piper Sandler reduz preço-alvo da Immuneering devido ao cronograma de lançamento
Piper Sandler cuts Immuneering stock price target on launch timing
Oppenheimer reitera classificação de ações da Immuneering após avanços no pipeline
Oppenheimer reiterates Immuneering stock rating on pipeline progress
Immuneering’s (IMRX) chief business officer buys $24,990 in stock
Diretor da Immuneering, Schall, compra ações no valor de US$ 101 mil
Diretora de pessoas da Immuneering, Neufeld, compra US$ 10.905 em ações IMRX
Diretor da Immuneering, Feinberg, compra US$ 86 mil em ações
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.55%